Literature DB >> 21556855

Expression analysis of epb41l4a during Xenopus laevis embryogenesis.

Yanchun Guo1, Kathleen S Christine, Frank Conlon, Susanne Gessert, Michael Kühl.   

Abstract

Epbl41l4a (erythrocyte protein band 4.1-like 4a, also named Nbl4) is a member of the band 4.1/Nbl4 (novel band 4.1-like protein 4) group of the FERM (4.1, ezrin, radixin, moesin) protein superfamily. Proteins encoded by this gene family are involved in many cellular processes such as organization of epithelial cells and signal transduction. On a molecular level, band 4.1/Nbl4 proteins have been shown to link membrane-associated proteins and lipids to the actin cytoskeleton. Epbl41l4a has also recently been identified as a target gene of the Wnt/β-catenin pathway. Here, we describe for the first time the spatio-temporal expression of epbl41l4a using Xenopus laevis as a model system. We observed a strong and specific expression of epb41l4a in the developing somites, in particular during segmentation as well as in the nasal and cranial placodes, pronephros, and neural tube. Thus, epbl41l4a is expressed in tissues undergoing morphogenetic movements, suggesting a functional role of epbl41l4a during these processes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21556855      PMCID: PMC3612984          DOI: 10.1007/s00427-011-0362-8

Source DB:  PubMed          Journal:  Dev Genes Evol        ISSN: 0949-944X            Impact factor:   0.900


  23 in total

Review 1.  Vertebrate anteroposterior patterning: the Xenopus neurectoderm as a paradigm.

Authors:  J Gamse; H Sive
Journal:  Bioessays       Date:  2000-11       Impact factor: 4.345

2.  Wnt3a plays a major role in the segmentation clock controlling somitogenesis.

Authors:  Alexander Aulehla; Christian Wehrle; Beate Brand-Saberi; Rolf Kemler; Achim Gossler; Benoit Kanzler; Bernhard G Herrmann
Journal:  Dev Cell       Date:  2003-03       Impact factor: 12.270

Review 3.  ERM proteins and merlin: integrators at the cell cortex.

Authors:  Anthony Bretscher; Kevin Edwards; Richard G Fehon
Journal:  Nat Rev Mol Cell Biol       Date:  2002-08       Impact factor: 94.444

Review 4.  The Wnt signaling pathway in development and disease.

Authors:  Catriona Y Logan; Roel Nusse
Journal:  Annu Rev Cell Dev Biol       Date:  2004       Impact factor: 13.827

Review 5.  The multiple phases and faces of wnt signaling during cardiac differentiation and development.

Authors:  Susanne Gessert; Michael Kühl
Journal:  Circ Res       Date:  2010-07-23       Impact factor: 17.367

Review 6.  Molecular basis of red cell membrane disorders.

Authors:  Jean Delaunay
Journal:  Acta Haematol       Date:  2002       Impact factor: 2.195

7.  Molecular cloning of a novel NF2/ERM/4.1 superfamily gene, ehm2, that is expressed in high-metastatic K1735 murine melanoma cells.

Authors:  K Shimizu; Y Nagamachi; M Tani; K Kimura; T Shiroishi; S Wakana; J Yokota
Journal:  Genomics       Date:  2000-04-15       Impact factor: 5.736

8.  Isolation and characterization of a novel human gene, DRCTNNB1A, the expression of which is down-regulated by beta-catenin.

Authors:  T Kawasoe; Y Furukawa; Y Daigo; T Nishiwaki; H Ishiguro; M Fujita; S Satoh; N Miwa; Y Nagasawa; Y Miyoshi; M Ogawa; Y Nakamura
Journal:  Cancer Res       Date:  2000-07-01       Impact factor: 12.701

9.  Zebrafish mosaic eyes is a novel FERM protein required for retinal lamination and retinal pigmented epithelial tight junction formation.

Authors:  Abbie M Jensen; Monte Westerfield
Journal:  Curr Biol       Date:  2004-04-20       Impact factor: 10.834

10.  Essential function of Wnt-4 for tubulogenesis in the Xenopus pronephric kidney.

Authors:  Didier M E Saulnier; Hedyeh Ghanbari; André W Brändli
Journal:  Dev Biol       Date:  2002-08-01       Impact factor: 3.582

View more
  1 in total

1.  Identification of key genes associated with esophageal adenocarcinoma based on bioinformatics analysis.

Authors:  Weifeng Qi; Rongyang Li; Lin Li; Shuhai Li; Huiying Zhang; Hui Tian
Journal:  Ann Transl Med       Date:  2021-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.